Health Trials

Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Study of Transcatheter Aortic Valve Replacement With A² Flex and Commissural Alignment Technology in Severe Aortic Stenosis

A prospective, single-center, single-group follow-up study of transcatheter aortic valve replacement with A² Flex and commissural alignment technology in severe aortic stenosis by Peijia Medical

Participants needed: 10
Trial details
Age: 60+Biological sex: AllType: InterventionalSponsor: Peijia Medical Technology (Suzhou) Co., Ltd.Updated: Dec 6, 2024Locations: 1
Eligibility criteria

Patients who are willing to participate and sign the informed consent and can co... [+4]

The left and right coronary ostiums originate from the junctional zone or from b... [+13]

Read more
Status: Recruiting

Safety and Efficacy of the GeminiOne Transcatheter Valve Edge-to-Edge Repair System in Patients With Moderate-severe or Severe Degenerative Mitral Regurgitation

To observe and evaluate the safety and efficacy of the GeminiOne Transcatheter Valve Edge-to-Edge Repair System in Patients With Moderate-severe or Severe Degenerative Mitral Regurgitation through a prospective, multicenter clinical trial using objective performance criteria.

Participants needed: 120
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Peijia Medical Technology (Suzhou) Co., Ltd.Updated: Jun 5, 2024Locations: 1
Eligibility criteria

Patients who volunteer to participate and sign an informed consent form, underst... [+10]

The presence of intra-cardiac space occupancy, thrombus, or bulky organisms as i... [+27]

Read more
Status: Recruiting

Safety and Effectiveness of TaurusTrio™ Heart Valve System in Patients With Severe Aortic Regurgitation (AR)

To evaluate the safety and effectiveness of the TaurusTrio™ Heart Valve System in a patient population with symptomatic severe AR requiring replacement/repair of their native aortic valve that are at high risk for open surgical aortic valve replacement/repair (SAVR).

Participants needed: 116
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Peijia Medical Technology (Suzhou) Co., Ltd.Updated: Mar 18, 2024Locations: 19
Eligibility criteria

Patients who voluntarily participate and sign the informed consent and are able... [+14]

Congenital uni- or bicuspid aortic valve morphology； [+29]

Read more
Status: Recruiting

Safety and Efficacy of the HighLife Transcatherter Mitral Valve Replacement System in Patients With Moderate-severe or Severe Mitral Regurgitation in China

To observe and evaluate the safety and efficacy of the HighLife Transcatheter Mitral Valve Replacement System in patients with moderate-severe or severe mitral valve regurgitation through a prospective, multicenter clinical trial using objective performance criteria.

Participants needed: 110
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Peijia Medical Technology (Suzhou) Co., Ltd.Updated: Nov 9, 2022Locations: 1
Eligibility criteria

Patients who voluntarily participate and sign the informed consent form and can... [+4]

Patients had any stroke/TIA within 30 days; [+31]

Read more